Targeting Vascular Inflammation In Patients with Community-Acquired Pneumonia (TIN-CAP): protocol for a multicentre, randomised, double-blind, placebo-controlled trial
Cameron Stotts(University of Ottawa), Kevin E. Boczar(University of Ottawa), Wendy Sligl(University of Alberta), Anahita Tavoosi, Djeven P. Deva(St. Michael's Hospital), Giovanni Ferrara(University of Modena and Reggio Emilia), Krishan Yadav(University of Ottawa), Katey J. Rayner(University of Ottawa), Kim A. Connelly(St. Michael's Hospital), Christiane Wiefels(University of Ottawa), Carlos Torres(University of Ottawa), Vicente Corrales‐Medina(Ottawa Hospital), Narinder Paul(London Health Sciences Centre), Paolo Raggi(University of Alberta), Vladimir Contreras-Domínguez(University of Ottawa), R Dekemp(University of Ottawa), R Beanlands(University of Ottawa), George A Wells(University of Ottawa), Melissa Brouwers(University of Ottawa), Anish Kirpalani(St. Michael's Hospital), Bruce Grey(St. Michael's Hospital), Jonathan Romsa(London Health Sciences Centre)
Cited by 0
Related Papers
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
|Nature|2010|4k
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
|Nature Immunology|2009|1.5k
MiR-33 Contributes to the Regulation of Cholesterol Homeostasis
|Science|2010|1.3k